Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of the Cultural Context of Sugars Consumption Behavior in Low-Income Mexican-American Women.

Journal of health disparities research and practice·2026
Same author

Letter to Editor: Associations of Fructose Consumption with Prevalence and Incidence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - the Kuopio Ischaemic Heart Disease Risk Factor Study.

The Journal of nutrition·2026
Same author

Patient-provider communication and the role of PrEP coordinators: a qualitative analysis to improve HIV preventive care.

Culture, health & sexuality·2026
Same author

Early-Life Nutritional Determinants of Pediatric MASLD.

Nutrients·2025
Same author

Hepatic steatosis in postmenopausal women is characterized by distinct serum extracellular vesicle proteomic signatures.

BMC medicine·2025
Same author

Digital Storytelling to Reduce Hispanic Parents' COVID-19 Vaccine Hesitancy: A Pilot Randomized Controlled Trial.

Vaccines·2025

Related Experiment Video

Updated: Jun 14, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Perimenopausal obesity.

Colleen Keller1, Linda Larkey, Johanna K Distefano

  • 1College of Nursing and Healthcare Innovation, Arizona State University, Phoenix, Arizona 85004, USA. colleen.keller@asu.edu

Journal of Women'S Health (2002)
|April 13, 2010
PubMed
Summary
This summary is machine-generated.

Obesity is a major risk factor for diseases like heart disease and diabetes. This review explores how menopause and other factors contribute to weight gain in aging women, suggesting an ecological approach for management.

Related Experiment Videos

Last Updated: Jun 14, 2026

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Area of Science:

  • Reproductive Endocrinology
  • Obesity Research
  • Public Health

Background:

  • Obesity is a significant risk factor for chronic diseases such as heart disease and diabetes.
  • Women, particularly during life transitions like menopause, are prone to weight gain.
  • Multiple interacting factors contribute to obesity, including energy intake, physical activity, and fat distribution.

Purpose of the Study:

  • To review the literature on weight change during perimenopause.
  • To examine contributing factors from an ecological perspective.
  • To recommend future research directions for weight management in women.

Main Methods:

  • Literature review using a multilevel perspective.
  • Analysis of factors across community, family, and individual levels.
  • Integration of biological, genetic, and behavioral predispositions.

Main Results:

  • Menopause triggers changes that can lead to weight gain in aging women.
  • The interaction of multiple factors determines an individual's risk for obesity.
  • An ecological framework is essential for understanding weight change in perimenopausal women.

Conclusions:

  • Weight management in perimenopausal women requires an integrated, multilevel approach.
  • Future research should focus on translational strategies tailored to women's unique needs.
  • Addressing obesity during perimenopause is crucial for long-term health outcomes.